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Dear Editor,
Cerebral ischemia is characterized by the activation of glial
cells, causing a rapid andmassive local inflammatory reaction
that leads to tissue damage and neuronal cell death.1 Over the
past decade, it has become increasingly clear that the
transcription factor nuclear factor kB (NF-kB) has a central
role in the pathogenesis of cerebral ischemia. The NF-kB
family consists of five members, RelA (p65), RelB, c-Rel, p50
and p52, all of which are activated in the ischemic hemisphere
of mice shortly after permanent middle cerebral artery
occlusion (pMCAO), a well-established rodent model of focal
cerebral ischemia.2 Furthermore, p50-deficient mice show a
reduction in ischemic damage after pMCAO and transient
MCAO followed by reperfusion, suggesting a cell death
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Figure 1 (a) pMCAO was induced in wild-type C57BL/6 mice and gene expression in the infarcted brain area was assessed by quantitative real-time PCR 24 h after
pMCAO. (b) A20 expression in primary cortical neurons, as assessed by quantitative real-time PCR. NBM, neurobasal medium supplemented with B27; -Gluc nO2, DMEM
without glucose in normoxic conditions; -Gluc hypoO2, DMEM without glucose in hypoxic conditions. **Po0.01; ***Po0.001 (c) pMCAO was induced in CNS- (A20CNS-KO,
n¼ 12) or neuron-specific (A20NEUR-KO, n¼ 6) A20-deficient mice and their control A20FL littermates (n¼ 9 and n¼ 12, respectively), as previously described.2
Representative silver-stained brain sections (left panel) and evaluation of infarcts volume (right panel) 24 h after pMCAO. Values are means±S.E.M.
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promoting role for NF-kB in this model.3,4 In addition, mice
lacking RelA in the central nervous system (CNS) also show
reduced infarct size after 48 h of pMCOA, whereas germline
deletion of the p52 or c-Rel subunits did not affect infarct
volume.2 In line with findings that NF-kB has a detrimental role
during ischemia, mice lacking IKK2 in all neuroectodermal
cells or specifically in neurons show a decreased infarct
volume 48h after pMCAO, whereas constitutive activation of
IKK2 increased infarct size.5 However, NF-kB may also act
beneficial in conditions of ischemic preconditioning, which
was shown to protect against a subsequent prolonged
ischemic insult through transcriptional activation of NF-kB.6
The ubiquitin editing enzyme A20 is a key negative
regulator of NF-kB signaling. Moreover, A20 can also act as
a strong antiapoptotic protein in specific cell types.7 Because
of the central role of A20 in controlling NF-kB and apoptotic
responses, we sought to further clarify its in vivo role in the
pMCAO mouse model of brain ischemia.
We demonstrate here that NF-kB driven genes such as
A20, TNF and IL-6 are upregulated in the infarcted area 24 h
post pMCAO (Figure 1a). We further questioned whether A20
would be differentially regulated in primary murine cortical
neurons after glucose oxygen deprivation, an in vitro model
mimicking pMCAO. In agreement with our in vivo data, A20
mRNA was upregulated in primary murine cortical neurons
when placed in a glucose deprived 0.1% O2 hypoxic
environment for 4 h (Figure 1b). As A20 is upregulated both
in vivo and in vitro during ischemic conditions, we questioned
whether mice lacking A20 specifically in the CNS (A20CNS-KO)
or exclusively in neurons (A20NEUR-KO) are affected differently
after pMCAO when compared with wild-type littermates.
A20CNS-KO and A20NEUR-KO mice were generated by crossing
mice carrying a floxed A20 allele8 to mice expressing cre-
recombinase under control of the nestin or thy1.2 promoter,
respectively. These A20CNS-KO or A20NEUR-KO mice, together
with control littermatemice, were subjected to pMCAO for 24 h
after which the infarct size was estimated by means of a silver
staining technique. To our surprise the infarct volume did not
differ between A20CNS-KO or A20NEUR-KO and their respective
wild-type control littermates (Figure 1c). Collectively, these
results clearly demonstrate that, although A20 is upregulated
in conditions of pMCAO, A20 deficiency in either all cells of
neuroectodermal origin, or more specifically in neurons, does
not influence the outcome of pMCAO in mice.
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